Low-Level Drinking Was Not Invisible to the Aging Cortex TL;DR: Even drinking within low-risk guidelines was linked to lower cortical blood flow and thinner cortex when lifetime exposure met advancing age. Key Findings All participants stayed under 60 drinks per month: The cohort excluded alcohol use disorder and focused on healthy non-smoking adults reporting low-level …
Ketamine Restored Reward Bias Across Species TL;DR: Ketamine restored reward-learning bias in both treatment-resistant depression and chronically stressed rats while leaving basic discrimination unchanged. Key Findings Reward bias increased: Ketamine significantly increased response bias toward the more frequently rewarded stimulus in both species. Healthy-control levels returned: The reward-bias effect reached levels comparable with healthy controls …
Cannabis Did Not Just Blur Word Lists. It Hit Everyday Memory Too TL;DR: A randomized vaporized-THC trial found broad acute memory impairment, including false memories, prospective memory, source memory, and temporal order memory, with no meaningful dose split between 20 and 40 mg. Key Findings 120 regular cannabis users randomized: Participants vaporized placebo cannabis, 20 …
150 mg Caffeine Did Not Trigger Panic Disorder Anxiety TL;DR: A normal coffee-sized caffeine dose did not trigger a subjective anxiety surge in panic disorder, but it did make people more physiologically aroused, more avoidant, and more distracted by bodily sensations. Key Findings 150 mg did not raise subjective anxiety: The primary outcome did not …
Hormone Therapy Linked to 44% Improvement in Menopause Mood Symptoms TL;DR: Menopausal hormone therapy tracked with a 44.59% improvement in mood-symptom scores after about 107 days, across both peri- and postmenopausal women — and the gains were broadly similar regardless of which hormonal regimen was used. Key Findings 44.59% improvement in mood symptoms: After initiating …
Caffeinated Coffee Linked to Lower Dementia Risk Over 43 Years TL;DR: Caffeinated coffee drinkers had 141 vs 330 dementia cases per 100,000 person-years in the highest versus lowest intake quartiles — across 131,821 adults followed up to 43 years. Decaf showed no comparable signal. Key Findings Caffeinated coffee: 141 vs 330 dementia cases per 100,000 …
Semaglutide Linked to 42% Fewer Psychiatric Hospital Episodes TL;DR: In Swedish registry data covering nearly 100,000 people with depression or anxiety, psychiatric hospital visits and sickness absence were 42% lower during semaglutide treatment periods — with comparable reductions in depression, anxiety, and substance-use outcomes. Key Findings 42% lower psychiatric care during semaglutide periods: Psychiatric hospital …
Metformin’s Secret Weapon: How the Brain Controls Blood Sugar TL;DR: Metformin’s glucose-lowering effect depends on a brain signaling pathway—it inhibits Rap1 in the hypothalamus, activating neurons that tell the liver to stop overproducing glucose. For decades, metformin has been the first-line drug for type 2 diabetes, working so reliably that millions take it daily. Yet …
How Lecanemab Clears Brain Amyloid: The Microglia Key TL;DR: Lecanemab, the first Alzheimer’s antibody to slow cognitive decline, works by activating immune cells called microglia through a specific immune signaling pathway, with the molecule SPP1/osteopontin playing a critical role in triggering the brain’s own cleanup machinery. When lecanemab was approved by the FDA, it sparked …
When Depression Threatens Pregnancy: A 34% Elevated Miscarriage Risk TL;DR: Untreated depression increases miscarriage risk by 34% across nearly 9 million women, but antidepressants reduce that risk to 24%—meaning the medication is safer than the disease during pregnancy. For decades, obstetricians have asked the wrong question about depression in pregnancy. They worried: Is the antidepressant …
